Navigation Links
Pneumococcal disease: More cases but fewer deaths
Date:5/7/2012

The vaccine given to children to immunise against serious pneumococcal disease does not offer full protection, reveals research from the Sahlgrenska Academy at the University of Gothenburg, Sweden, finding that the number of cases diagnosed has tripled over the past 50 years.

Each year an estimated 1 million children worldwide die as a result of pneumococcal disease. Worst affected are those in poor countries, but pneumococcal bacteria cause disease and suffering in all age groups and in all countries, including Sweden.

There are currently two types of active vaccine: polysaccharide vaccines, which protect against more types of pneumococcal bacteria but cannot be given to children under the age of two, and conjugated vaccines, which can be given to infants but protect against fewer types.

In his thesis, Erik Backhaus, infection specialist at Skvde Hospital and doctoral student at the University of Gothenburg's Sahlgrenska Academy, looks at all cases of serious pneumococcal disease in children and adults in the Vstra Gtaland region of Sweden between 1998 and 2001. His studies show that the latest conjugated vaccines theoretically offer protection against around 70% of infections. "But around 95% of infections are caused by serotypes covered by the polysaccharide vaccine," says Backhaus. "This vaccine cannot be administered to children under two years of age, which means that it cannot be used in those who need it most."

Risk of death is age-related

In the worst case, the bacteria cause serious disease from which around 10% of patients die within a month of diagnosis. Erik Backhaus shows in his thesis that the risk of dying depends partly on age and partly on underlying medical conditions, but also that the risk is higher for men than women. Interestingly there are also geographical variations: fewer serious pneumococcal infections are diagnosed in the over-80s in the Gothenburg area than in other parts of the Vstra Gtaland region.

"This may be due to different routines for admitting patients from nursing homes to hospital and how often blood cultures are performed," he explains.

More cases, fewer deaths

Over the past 45 years the number of cases of severe pneumococcal disease diagnosed in the Gothenburg area has tripled from 5 to 15 cases per 100,000 inhabitants per year. This is probably because many more blood cultures are performed these days, meaning that more cases are detected. Erik Backhaus' thesis shows that the risk of dying as a result of serious pneumococcal disease has fallen sharply since the 1960s, especially among children and young adults.

It is hoped that the recently introduced pneumococcal vaccination as part of the standard child immunisation programme will reduce the number of infections among both children and adults.


'/>"/>
Contact: Erik Backhaus
erik.backhaus@vgregion.se
University of Gothenburg
Source:Eurekalert  

Related medicine news :

1. Vaccine Now Misses Many Pneumococcal Infections in Kids
2. GSK Joins Global Vaccine Alliance to Help Prevent Millions of Children from Contracting Pneumococcal Disease in the Worlds Poorest Countries
3. Young Kids to Benefit From Broader Pneumococcal Vaccine
4. Ob/Gyn Visit a Good Time to Screen for Heart Disease: Study
5. Northeast U.S. Should Brace for Spike in Lyme Disease: Expert
6. Inflammation Might Play Role in Heart Disease: Study
7. Experimental Drug Offers Hope for Rare Bone Disease: Study
8. Physiology of cardiovascular disease: Gender disparities
9. Alzheimers disease: The first prevention study of its kind
10. Braunwalds Heart Disease: A Textbook of Cardiovascular Medicine comes to the app store
11. Millions Dont Get Meds for Serious Artery Disease: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pneumococcal disease: More cases but fewer deaths
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 ... characterized by frequent cessation in breathing. Oral appliances can offer significant relief to ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical (AVACEN) ... is now successfully helping those with the widespread pain ... Fibromyalgia diagnosed Amanda in Essex, England ... washing my hair, experiencing no sleep at all, tremendous ... spasm… I cannot recommend [the AVACEN 100] enough, how ...
Breaking Medicine Technology: